NARDONE, Gerardo
 Distribuzione geografica
Continente #
AS - Asia 14.180
NA - Nord America 11.878
EU - Europa 8.837
SA - Sud America 1.928
AF - Africa 328
OC - Oceania 16
Continente sconosciuto - Info sul continente non disponibili 14
Totale 37.181
Nazione #
US - Stati Uniti d'America 11.378
SG - Singapore 6.809
RU - Federazione Russa 4.028
CN - Cina 2.548
VN - Vietnam 2.208
BR - Brasile 1.527
IT - Italia 1.254
HK - Hong Kong 1.180
FR - Francia 548
DE - Germania 546
UA - Ucraina 515
FI - Finlandia 473
IE - Irlanda 401
NL - Olanda 294
IN - India 280
JP - Giappone 278
CA - Canada 252
GB - Regno Unito 236
SE - Svezia 214
MX - Messico 157
AR - Argentina 154
BD - Bangladesh 113
KR - Corea 104
IQ - Iraq 89
PK - Pakistan 83
ZA - Sudafrica 82
EC - Ecuador 78
PL - Polonia 72
ES - Italia 70
PH - Filippine 64
TH - Thailandia 60
TR - Turchia 58
CI - Costa d'Avorio 57
ID - Indonesia 57
AT - Austria 41
TW - Taiwan 41
CO - Colombia 36
MA - Marocco 29
JO - Giordania 26
PE - Perù 26
VE - Venezuela 26
BE - Belgio 25
CL - Cile 24
KE - Kenya 23
PY - Paraguay 22
UZ - Uzbekistan 22
DZ - Algeria 20
EG - Egitto 20
NP - Nepal 18
LT - Lituania 17
BO - Bolivia 16
UY - Uruguay 16
JM - Giamaica 15
CR - Costa Rica 14
IR - Iran 13
KZ - Kazakistan 13
MY - Malesia 13
TN - Tunisia 13
AE - Emirati Arabi Uniti 11
EU - Europa 11
HN - Honduras 11
IL - Israele 11
LB - Libano 11
SA - Arabia Saudita 11
CZ - Repubblica Ceca 10
DO - Repubblica Dominicana 10
RO - Romania 10
ET - Etiopia 9
LV - Lettonia 9
RS - Serbia 9
TT - Trinidad e Tobago 9
AU - Australia 8
CH - Svizzera 8
AO - Angola 7
HR - Croazia 7
KG - Kirghizistan 7
AM - Armenia 6
AZ - Azerbaigian 6
CM - Camerun 6
GA - Gabon 6
HU - Ungheria 6
NG - Nigeria 6
OM - Oman 6
BG - Bulgaria 5
BY - Bielorussia 5
GE - Georgia 5
KH - Cambogia 5
PA - Panama 5
PS - Palestinian Territory 5
PT - Portogallo 5
SY - Repubblica araba siriana 5
BW - Botswana 4
ML - Mali 4
SB - Salomone, isole 4
VC - Saint Vincent e Grenadine 4
BS - Bahamas 3
BZ - Belize 3
CG - Congo 3
CW - ???statistics.table.value.countryCode.CW??? 3
DK - Danimarca 3
Totale 37.078
Città #
Singapore 3.069
San Jose 1.794
Hong Kong 1.142
Moscow 978
Chandler 844
Ashburn 673
Ho Chi Minh City 606
Beijing 532
Hanoi 517
Jacksonville 516
Santa Clara 487
The Dalles 444
Millbury 430
Princeton 384
Lauterbourg 381
Hefei 371
Los Angeles 327
Naples 287
Woodbridge 282
Nanjing 264
Tokyo 262
Boston 255
Amsterdam 237
Buffalo 190
Houston 167
New York 159
Munich 153
Wilmington 151
São Paulo 139
Ann Arbor 138
Napoli 131
Ottawa 118
Redondo Beach 103
Da Nang 96
Nanchang 96
Dallas 88
Haiphong 78
Shenyang 75
Norwalk 69
Rome 69
Seoul 67
Hebei 66
Mexico City 64
Des Moines 63
Frankfurt am Main 59
Orem 57
Cagliari 56
Chicago 55
Brooklyn 54
Turku 53
Seattle 52
Warsaw 51
Montreal 48
Rio de Janeiro 48
Tianjin 48
Milan 47
Jiaxing 46
Changsha 45
Denver 44
Kronberg 44
Chennai 43
Johannesburg 43
Nuremberg 42
Falls Church 41
Helsinki 41
Council Bluffs 39
Kochi 38
Toronto 38
Belo Horizonte 36
Boardman 36
Biên Hòa 34
Washington 34
Atlanta 33
Baghdad 33
Phoenix 33
San Francisco 32
Hải Dương 30
London 30
Lawrence 29
Guayaquil 27
Orange 27
Stockholm 27
Curitiba 26
Poplar 26
Manchester 25
Dong Ket 24
Amman 23
Ankara 23
Mumbai 23
Ninh Bình 23
Porto Alegre 23
Nairobi 22
Hangzhou 21
Quito 21
Tashkent 21
Vienna 21
Can Tho 20
Erbil 20
Falkenstein 20
Lahore 20
Totale 19.337
Nome #
Vascular endothelial growth factor and cyclooxygenase-2 are overexpressed in ileal pouch-anal anastomosis. 266
1st Rome H2-Breath Testing Consensus Conference Working Group. Methodology and indications of H2-breath testing in gastrointestinal diseases: the Rome Consensus Conference. 219
Economic Consequences of Investing in Anti-HCV Antiviral Treatment from the Italian NHS Perspective: A Real-World-Based Analysis of PITER Data 190
Reproducibility of shear wave elastography (SWE) in patients with chronic liver disease 178
A holistic evaluation of patients with chronic Hepatitis D virus (HDV) infection enrolled in the Italian PITER-B and delta cohort 176
Ombitasvir, paritaprevir, and ritonavir, with or without dasabuvir, plus ribavirin for patients with hepatitis C virus genotype 1 or 4 infection with cirrhosis (ABACUS): a prospective observational study 170
Vitamin B12 supplementation improves rates ofsustained viral response in patients chronicallyinfected with hepatitis C virus 162
Gastric Normal Adjacent Mucosa Versus Healthy and Cancer Tissues: Distinctive Transcriptomic Profiles and Biological Features 162
Alcoholic disease: Liver and beyond 159
Clinical features and comorbidity pattern of HCV infected migrants compared to native patients in care in Italy: A real-life evaluation of the PITER cohort 158
Sweetened carbonated drinks do not alter upper digestive tract physiology in healthy subjects 158
Quantitative analysis of aldolase A mRNA in liver discriminates between hepatocellular carcinoma and cirrhosis. 156
Nutritional state and energy balance in cirrhotic patients with or without hypermetabolism Multicentre prospective study by the 'Nutritional Problems in Gastroenterology' Section of the Italian Society of Gastroenterology 154
Adherence to Barcelona Clinic Liver Cancer guidelines in field practice: Results of Progetto Epatocarcinoma Campania 151
Risk factors for cancer development in helicobacter pylori gastritis. 148
Trends in chronic hepatitis B virus infection in Italy over a 10-year period: Clues from the nationwide PITER and MASTER cohorts toward elimination 147
MANUALE DI GASTROENTEROLOGIA DIETISTI 146
Esofago di Barrett 145
Quality of bowel cleansing in hospetalized patients undergoing colonoscopy: a multicenter prospective regional study 145
Large Brunner's gland adenoma: Case report and literature review. 142
Ultrasonographic diagnosis of ileo-ileal intussusception secondary to Vanek's tumor 140
Material deprivation affects the management and clinical outcome of hepatocellular carcinoma in a high-resource environment 139
A RAT MODEL OF OXIDATIVE AND METABOLIC HEPATIC INJURY: THE POTENTIAL PROTECTIVE ROLE OF LACTOBACILLUS PARACASEI F19 139
Long-lasting intestinal bleeding in an old patient with multiple mucosal vascular abnormalities and Glanzmann's thrombasthenia: 3-year pharmacological management. 138
Surveillance for hepatocellular carcinoma with a 3-months interval in “extremely high-risk” patients does not further improve survival 137
Characteristics and survival of patients with primary biliary cholangitis and hepatocellular carcinoma 137
Pattern of macrovascular invasion in hepatocellular carcinoma 136
Potential feasibility of atezolizumab-bevacizumab therapy in patients with hepatocellular carcinoma treated with tyrosine-kinase inhibitors 135
Incidence and distribution of coeliac disease in Campania (Italy): 2011-2013 135
Overview of prognostic systems for hepatocellular carcinoma and ITA.LI.CA external validation of MESH and CNLC classifications 134
Intestinal amyloidosis: two cases with different patternsof clinical and imaging presentation 134
The metabolic role of gut microbiota in the development of nonalcoholic fatty liver disease and cardiovascular disease 134
Laser ablation is superior to TACE in large-sized hepatocellular carcinoma: A pilot case-control study 133
The dica endoscopic classification for diverticular disease of the colon shows a significant interobserver agreement among community endoscopists: An international study 133
Relationship between cyclooxygenese-2 and p-glycoprotein expression in H. pylori- positive gastritis non responders to eradication therapy 132
Lactobacillus paracasei F19 versus placebo for the prevention of proton pump inhibitor-induced bowel symptoms: A randomized clinical trial 132
Impact of proton pump inhibitors on cytochrome P450 activity assessed by 13C-aminopyrine breath test in patients with cirrhosis 132
The “dica” endoscopic classification for diverticular disease of the colon shows a significant interobserver agreement among community endoscopists 131
Gut Microbes and Hepatic Encephalopathy: From the Old Concepts to New Perspectives 130
Non-bismuth and bismuth quadruple therapies based on previous clarithromycin exposure are as effective and safe in an area of high clarithromycin resistance: A real-life study 130
Genome-wide analysis of 53,400 people with irritable bowel syndrome highlights shared genetic pathways with mood and anxiety disorders 129
Is screening for and surveillance of atrophic gastritis advisable? 129
Blinded oral challenges with lactose and placebo accurately diagnose lactose intolerance: a real‐life study 128
Gastrokine 1 expression in patients with and without Helicobacter pylori infection. 128
Probiotics in Gastrointestinal Diseases: All that Glitters Is Not Gold 127
Age-specific prevalence of Helicobacter pylori infection and morphological findings of gastric mucosa. A retrospective study in a symptomatic pediatric population of southern Italy. 127
Cd133 and Cd44 Cell Surface Markers Do Not Identify Cancer Stem Cells In Primary Human Gastric Tumours 126
Invasive pulmonary aspergillosis and pulmonary tuberculosis in a patient treated with infliximab for Crohn's disease 126
Autoimmune liver diseases and SARS-CoV-2 125
Performance characteristics of an enzime-linked immunosorbent assay for determining salivary immunoglobulin G response to Helicobacter Pylori 125
Apoptosis and cytologic differentiation in hepatocellular carcinoma on fine needle aspiration samples. 125
Transarterial Chemoembolization for Hepatocellular Carcinoma in Clinical Practice: Temporal Trends and Survival Outcomes of an Iterative Treatment 124
Coeliac diseas and unfavourable outcome of pregnancy. 124
Changes of protein expression in Helicobacter pylori-infected human gastric mucosa 124
Lactobacillus casei DG and its postbiotic reduce the inflammatory mucosal response: An ex-vivo organ culture model of post-infectious irritable bowel syndrome 124
Gastro-duodenal lesions and Helicobacter pylori infection in dyspeptic patients with and without chronic renal failure 123
Matrix metalloproteinase-9expression and polyphenols extracts effect on MKN-28 cells 123
Gastric atrophy and intestinal metaplasia changes 8 years after Helicobacter pylori eradication. A blind, randomised study. 122
I livelli tessutali di grelina non correlano con il tempo di svuotamento gastrico 121
CD133 and CD44 Cell surface markers do not identify cancer stem cells in primary human gastric tumors 121
Cell proliferation and genomic instability in chronic gastritis, with and without Helicobacter pylori infection, and in gastric cancer. 121
Sexual dysfunctions in inflammatory bowel disease: role of Mediterranean diet and quality of life 121
Development of a risk score to predict portal vein tumor thrombosis in patients with hepatocellular carcinoma 120
Liver Resection vs Nonsurgical Treatments for Patients With Early Multinodular Hepatocellular Carcinoma 120
Altered trafficking of EGF in endocytic proliferation and innate immunity markers in MARSH 0 (M0) biopsies of celiac patients. 120
MDR1-P-glycoprotein behaves as an oncofetal protein that promotes cell survival in gastric cancer cells 120
Plasma dosage of ghrelin, IGF-1, GLP- 1 and leptin related to gastric emptying and esophageal pH-impedance in children with obesity 120
13C-AMINOPYRINE BREATH TEST PREDICTS THE CLINICAL OUTCOME IN PATIENTS WITH C VIRUS-RELATED CHRONIC HEPATITIS 118
Effects of long-term PPI treatment on producing bowel symptoms and SIBO 118
Gut--liver axis: the impact of gut microbiota on non alcoholic fatty liver disease 118
Gut microbiota and irritable bowel syndrome 117
Predicting de-novo portal vein thrombosis after HCV eradication: A long-term competing risk analysis in the ongoing PITER cohort 116
Effect of Helicobacter Pylori infection and its eradication on cell proliferation, DNA status, and oncogene expression in patients with chronic gastritis. 116
Molecular basis of gastric carcinogenesesis 116
Gastric Emptying Impacts the Timing of Meal Glucose Peak in Subjects with Uncomplicated Type 1 Diabetes 116
Diagnosis of chronic atrophic gastritis by morphometric image analysis. A new method to overcome the confounding effect of the inflammatory infiltrate. 115
A nomogram-based prognostic model for advanced hepatocellular carcinoma patients treated with sorafenib: A multicenter study 115
The professional background of a referring physician predicts the diagnostic yield of small bowel capsule endoscopy in suspected small bowel bleeding 114
POLYPHENOL EXTRACTS PROTECT GASTRIC CANCER CELLFROM OXIDATIVE STRESS-INDUCED DAMAGE 114
Characteristics and outcome of anti-hepatitis D virus positive patients with hepatocellular carcinoma 113
Helicobacter pylori and epigenetic mechanisms underlying gastric carcinogenesis. 113
Female-Specific Association Between Variants on Chromosome 9 and Self-Reported Diagnosis of Irritable Bowel Syndrome 113
Effects of carbonated water on functional dyspepsia and constipation. 112
Effect of Helicobacter Pylori infection on gastric cell proliferation and genomic instability in a paediatric population of southern Italy. 112
Cell proliferation, apoptosis and DNA-ploidy of gastric mucosa in Helicobacter pylori infection 112
Gastric emptying time and prevalence of small intestinal bacterial overgrowth in newly diagnosed celiac disease patients 112
Bowel movement alterations predict the severity of diverticular disease and the risk of acute diverticulitis: a prospective, international study 110
Mdr1 P-glycoprotein expression in human gastric tissue: From ontogenesis to carcinogenesis 110
Increased severity of dyspeptic symptoms related to mental stress is associated with sympathetic hyperactivity and enhanced endocrine response in patients with postprandial distress syndrome 110
Increased prevalence of rare sucrase-isomaltase (SI) pathogenic variants in irritable bowel syndrome patients 110
Epidemiological trends and trajectories of MAFLD-associated hepatocellular carcinoma 2002-2033: the ITA.LI.CA database 109
MDR1-P-glycoprotein behaves as an oncofetal protein that promotes cell survival in gastric cancer cells 109
MDR1-P-glycoprotein behaves as an oncofetal protein that promotes cell survival in gastric cancer cells 109
Diagnostic accuracy of the serum profile of gastric mucosa in relation to histological and morphometric diagnosis of atrophy 108
A mannose-binding lectin-defective haplotype is a risk factor for gastric cancer. 108
Up-regulation of heparin binding epidermal growth factor-like growth factor and amphiregulin expression in Helicobacter pylori-infected human gastric mucosa. 108
Modeling cost-effectiveness and health gains of a “universal” versus “prioritized” hepatitis C virus treatment policy in a real-life cohort 108
Green tea polyphenols affect invasiveness of human gastric MKN-28 cells by inhibition of LPS or TNF-α induced Matrix Metalloproteinase-9/2 108
Autoimmune hepatitis following SARS-CoV-2 vaccine: May not be a casuality 107
Biochemical analytes and clinical data in hepatology 107
Totale 13.067
Categoria #
all - tutte 118.635
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 118.635


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021165 0 0 0 0 0 0 0 0 0 0 134 31
2021/20222.008 25 1 7 33 5 56 8 72 410 108 342 941
2022/20232.115 426 138 46 171 257 240 14 191 273 234 105 20
2023/20241.534 60 223 222 114 71 138 15 183 25 33 329 121
2024/202510.006 567 788 61 123 256 436 1.112 528 1.150 934 3.119 932
2025/202617.500 2.043 1.372 1.843 1.488 3.056 699 1.887 1.371 2.306 1.122 313 0
Totale 37.660